Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micralyne developed and manufactured commercial-scale MEMS devices, including microfluidic technologies for biomedical and life science applications. The company was recognized for its unique expertise in non-silicon-based MEMS compatible with human body use. It was acquired by Teledyne Technologies in 2019 to complement Teledyne’s existing high-volume foundry capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micralyne.